Found: 11
Select item for more details and to access through your institution.
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo.
- Published in:
- Oncogene, 2007, v. 26, n. 13, p. 1829, doi. 10.1038/sj.onc.1209987
- By:
- Publication type:
- Article
D15 Effects of acetylsalicylic acid administration on liver CYP1A, UGT and antioxidant enzymes in a rat model of dimethylbenzanthracene (DMBA)-induced mammary carcinogenesis.
- Published in:
- Journal of Veterinary Pharmacology & Therapeutics, 2006, v. 29, n. S1, p. 125, doi. 10.1111/j.1365-2885.2006.00762_17.x
- By:
- Publication type:
- Article
Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-β1.
- Published in:
- Rhinology, 2012, v. 50, n. 4, p. 427, doi. 10.4193/rhino11.249
- By:
- Publication type:
- Article
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Heidenhain variant of Creutzefeldt–Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 1, p. 21, doi. 10.1038/bjc.2012.556
- By:
- Publication type:
- Article
Digital therapeutics in neurology.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1209, doi. 10.1007/s00415-021-10608-4
- By:
- Publication type:
- Article
SAR444245, a non‐alpha IL2, rescues chronic antigen and CAR‐driven T‐cell dysfunction.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 515, doi. 10.1002/hon.3164_381
- By:
- Publication type:
- Article
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
- Published in:
- Neurogenetics, 2018, v. 19, n. 2, p. 77, doi. 10.1007/s10048-018-0540-1
- By:
- Publication type:
- Article
Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats.
- Published in:
- Basic Research in Cardiology, 2011, v. 106, n. 3, p. 409, doi. 10.1007/s00395-010-0143-y
- By:
- Publication type:
- Article